The Investor’s Insider:
Protecting Against Securities Fraud

London Whale Class Action Proceeding Against JPMorgan

Posted on: April 24th, 2014 by Nadine Gartner

Steve Larson describes a shareholder class action against JPMorgan on our class actions blog.  Read about it here.

“What’s Right With Securities Class Action Lawsuits”

Posted on: March 18th, 2014 by Nadine Gartner

Public Citizen, a national nonprofit organization that represents consumer interests, recently published a report extolling the benefits and advantages of securities class action lawsuits.  Read more…

Stoll Berne Investigates Galena Biopharma

Posted on: February 20th, 2014 by Nadine Gartner

Our firm is investigating potential claims concerning whether Galena Biopharma, Inc. (“Galena”) (NASDAQ: GALE), its board of directors and/or officers violated state or federal securities laws, or breached fiduciary duties owed to shareholders. Read more…

U.S. Supreme Court to Review Stock Drop Case

Posted on: January 14th, 2014 by Nadine Gartner

The United States Supreme Court has granted certiori in Fifth Third Bancorp v. Dudenhoeffer, No. 12-751.  The question before the court is whether plaintiffs must allege that the fiduciaries of a stock plan abused their discretion by remaining invested in employer stock to overcome the presumption that the decision to invest in employer stock was reasonable. Read more…

FINRA Settles Case Against Oppenheimer & Co., Inc. Relating to Alleged Sales of Over One Billion Shares of Unregistered Penny Stocks

Posted on: August 6th, 2013 by Mark Friel

On August 5, 2013, the Financial Industry Regulatory Authority (“FINRA”) agreed to settle a case in which the regulatory organization alleged that Oppenheimer & Co., Inc. (“Oppenheimer”) had sold unregistered securities in violation of Section 5 of the Securities Act of 1933, failed to adequately supervise the sale of low-priced securities, failed to follow up on red flags involving the customers, sales and account activity, and failed to monitor patterns of suspicious activity that should have been identified and investigated through the company’s anti-money laundering program. Read more…

Fifth Circuit Rejects Halliburton’s Attempt to Defeat Class Certification With Price Impact Evidence

Posted on: May 14th, 2013 by Mark Friel

On April 30, 2013, the U.S. Court of Appeals for the Fifth Circuit, on remand from the U.S. Supreme Court, issued a decision in the securities fraud case of Erica P. John Fund, Inc. v. Halliburton Co.  In EPJ Fund, the Fifth Circuit rejected Halliburton’s attempt to defeat class certification by offering evidence of the absence of price impact. Relying on the earlier decision of the Supreme Court in Amgen v. Conn. Ret. Plans and Trust Funds, 133 S. Ct. 1184 (2013), the Fifth Circuit first explained that, while a misrepresentation’s materiality must at some point be proven in order to invoke the “fraud-on-the-market” presumption of reliance, the resolution of the question presents a common issue that affects all class members’ claims equally. Next, the court held that because Halliburton’s price impact evidence was offered only for the purpose of generally rebutting the presumption of reliance, and affected the ability of all class members to succeed on the merits of their claim, it could not be considered at class certification.

Oregon Supreme Court Rules That Proof of Reliance in Oregon Securities Law Action Can Be Established Via the Fraud-on-the-Market Doctrine

Posted on: December 13th, 2012 by Keith Ketterling

On December 13, 2012, the Oregon Supreme Court ruled unanimously that a plaintiff who brings a claim for damages based on misrepresentations under ORS 59.137(1) must establish that the plaintiff relied on the misrepresentations, but that proof of reliance can be established through the rebuttable presumption available under the fraud-on-the-market doctrine.  Read more…

Judge Grants Class Certification Over False Claims by Radient Pharmaceuticals

Posted on: December 4th, 2012 by Nadine Gartner

A federal judge in the Central District of California has certified a class of investors in a pending securities fraud lawsuit against Radient Pharmaceuticals. Read more…

Pfizer Settles Class Action Lawsuit by Former Wyeth Shareholders

Posted on: November 15th, 2012 by Keith Dubanevich

Pfizer Inc. (“Pfizer”), the world’s largest pharmaceutical company, has agreed to pay $67.5 million to settle a class action lawsuit by shareholders of the former Wyeth Inc. (“Wyeth”), a pharmaceutical company bought by Pfizer in 2009.  Read more…

Supreme Court Hears Case About Material Misstatements

Posted on: November 12th, 2012 by Nadine Gartner

In a previous post, we discussed that the Supreme Court had granted certiorari in Amgen Inc. v. Connecticut Retirement Plans.  The Court heard that case on Monday, November 5, 2012. Read more…

Public Corporations Use Foreign Tax Reserves to Manipulate Earnings

Posted on: October 30th, 2012 by Keith Dubanevich

A recent study demonstrates that a little-known accounting rule not only allows companies to set aside billions of dollars in overseas profits free of United States’ tax, but also helps public corporations manipulate their earnings.  Read more…

Business Groups Sue SEC Over Dodd-Frank Anti-Bribery Rule

Posted on: October 26th, 2012 by Nadine Gartner

A lawsuit filed by four business groups, including the U.S. Chamber of Commerce and American Petroleum Institute, alleges that the U.S. Securities and Exchange Commission (“SEC”) failed to adequately weigh the costs and benefits of a new rule requiring oil, mining, and gas companies to disclose payments made to foreign governments.  The lawsuit is the latest in a string of legal challenges against regulators still finalizing dozens of rules included in the 2010 Dodd-Frank Wall street reform law. Read more…

Legal Disclaimer

The information contained in this blog does not constitute legal advice, and does not create an attorney-client relationship. We make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this blog.

About this blog

The purpose of this blog is to provide information to the general public and to practitioners about developments that may impact Oregon investors.

About the authors

  • Nadine Gartner

  • Nadine Gartner
  • Nadine Gartner’s practice focuses on complex business litigation and class actions. Prior to becoming a lawyer, Nadine worked as an investment banking analyst.
  • Mark Friel

  • Nadine Gartner
  • Mark Friel is a litigation attorney who practices in the areas of complex business, consumer, securities, antitrust, and class action litigation. He is a shareholder at the law firm of Stoll Berne in Portland, Oregon.
  • Keith Dubanevich

  • Nadine Gartner
  • Keith Dubanevich has extensive experience handling antitrust, consumer and securities cases. Until joining the Portland, Oregon law firm Stoll Berne as a shareholder, he was the Associate Attorney General and Chief of Staff at the Oregon Department of Justice.
Follow stollberne on Twitter

Subscribe to this blog